Centro Regional de Investigaciones Biomédicas, Universidad de Castilla-La Mancha, Albacete, Spain.
Antiviral Res. 2010 Jul;87(1):57-66. doi: 10.1016/j.antiviral.2010.04.009. Epub 2010 Apr 27.
Hepatitis C virus (HCV) is a positive-strand RNA virus ((+)RNA) that replicates its genome in replication complexes (RC) associated to endoplasmic reticulum (ER)-derived micro-vesicles. One key protein in these complexes is NS5B, a viral enzyme that shows the RNA binding and RNA-dependent RNA polymerase (RdRp) activities. For this reason, NS5B protein has become one of the most important targets for designing new antiviral therapy compounds. Recently, it has been demonstrated that NS5B interacts itself forming oligomers, and mutations that disrupt these interactions are lethal for polymerase function. Therefore, NS5B oligomerization could be a new target for the design of anti-HCV compounds. In this study we describe a new accurate method to analyze NS5B-NS5B interactions by using Förster-resonance-energy transfer (FRET). This method allows analyses of the conditions, mainly ionic strength, driving the interactions between NS5B-cyan and NS5B-citrine constructs. Experiments using different combinations of point mutants rendered FRET values from zero to around 100%, suggesting the geometry of the interaction. Finally, oligomerization experiments in the presence of non-nucleoside inhibitor (NNI) PF-254027 gave a statistically significant reduction in the FRET signal, suggesting a new connection between NS5B oligomerization and NNI binding.
丙型肝炎病毒 (HCV) 是一种正链 RNA 病毒 ((+)RNA),其基因组在与内质网 (ER) 衍生的微泡相关的复制复合物 (RC) 中复制。这些复合物中的一个关键蛋白是 NS5B,这是一种具有 RNA 结合和 RNA 依赖性 RNA 聚合酶 (RdRp) 活性的病毒酶。因此,NS5B 蛋白已成为设计新型抗病毒治疗化合物的最重要靶标之一。最近,已经证明 NS5B 自身相互作用形成寡聚物,并且破坏这些相互作用的突变对聚合酶功能是致命的。因此,NS5B 寡聚化可能成为设计抗 HCV 化合物的新靶标。在这项研究中,我们描述了一种新的准确方法,通过使用Förster 共振能量转移 (FRET) 来分析 NS5B-NS5B 相互作用。该方法允许分析主要是离子强度的条件,驱动 NS5B-青色和 NS5B-黄色构建体之间的相互作用。使用不同点突变体组合进行的实验产生了从 0 到约 100%的 FRET 值,这表明了相互作用的几何形状。最后,在存在非核苷抑制剂 (NNI) PF-254027 的情况下进行的寡聚化实验,FRET 信号明显降低,表明 NS5B 寡聚化和 NNI 结合之间存在新的联系。